Skip to Main Content

File this under: “If at first you don’t succeed …”

After being rebuffed by a federal appeals court last summer, Allergan (AGN) and the St. Regis Mohawk Tribe have asked the U.S. Supreme Court to decide a vexing question that was at the heart of a controversial maneuver to protect a best-selling eye medicine.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED